Industry Presentations

Updated Data for a CML Treatment Option


  • NON

    A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy

    Speakers:Vamsi Kota, MD

    Duration: 60 minutes

    Presented on: December 1, 2021

    *This session is not eligible for AMA PRA Category 1 CreditsTM